Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NPY mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of NPY mRNA | decreases expression | 19497417
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of NPY protein | decreases expression | 19497417
|
D000661 |
Amphetamine |
NPY protein results in decreased susceptibility to Amphetamine | decreases response to substance | 12183048
|
D000661 |
Amphetamine |
Amphetamine affects the expression of NPY protein | affects expression | 16896163
|
D000661 |
Amphetamine |
Amphetamine results in decreased expression of NPY mRNA | decreases expression | 16896163 16101753 16084549 15680483
|
D000661 |
Amphetamine |
Amphetamine results in decreased expression of NPY protein | decreases expression | 15680483 12005258
|
D000661 |
Amphetamine |
Amphetamine results in increased expression of NPY mRNA | increases expression | 15183010
|
D000661 |
Amphetamine |
FOS protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA] | decreases expression|increases reaction | 16084549
|
D000661 |
Amphetamine |
JUN protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA] | decreases expression|increases reaction | 16084549
|
D000661 |
Amphetamine |
NPY protein affects the susceptibility to Amphetamine | affects response to substance | 16101753
|
D000661 |
Amphetamine |
NPY protein results in increased susceptibility to Amphetamine | increases response to substance | 12005258
|
D000661 |
Amphetamine |
PRKCA protein promotes the reaction [Amphetamine results in decreased expression of NPY mRNA] | decreases expression|increases reaction | 16101753
|
D001218 |
Aspartame |
Aspartame results in decreased expression of NPY protein | decreases expression | 11890951
|
C074212 |
bis(maltolato)oxovanadium(IV) |
bis(maltolato)oxovanadium(IV) results in increased expression of NPY mRNA | increases expression | 11398143
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of NPY mRNA | increases expression | 18180321
|
D002211 |
Capsaicin |
Capsaicin inhibits the reaction [NPY protein affects the susceptibility to Potassium] | affects response to substance|decreases reaction | 18055875
|
D002217 |
Carbachol |
NPY protein inhibits the reaction [Carbachol results in increased secretion of GCG protein] | decreases reaction|increases secretion | 3329090
|
D003024 |
Clozapine |
Clozapine results in decreased expression of NPY mRNA | decreases expression | 16516965
|
D003345 |
Corticosterone |
Corticosterone results in decreased expression of NPY mRNA | decreases expression | 15755911
|
D016047 |
Zalcitabine |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of NPY mRNA | affects cotreatment|increases expression | 18606552
|
D003847 |
Deoxyglucose |
Deoxyglucose results in increased expression of NPY mRNA | increases expression | 10683841
|
D019422 |
Dietary Sucrose |
Dietary Sucrose results in decreased expression of NPY mRNA | decreases expression | 18627777
|
D000431 |
Ethanol |
Ethanol results in decreased expression of NPY mRNA | decreases expression | 11095510
|
D005632 |
Fructose |
Fructose results in decreased expression of NPY mRNA | decreases expression | 18627777
|
D005947 |
Glucose |
Glucose deficiency results in increased expression of NPY mRNA | increases expression | 11177238
|
D005947 |
Glucose |
Glucose results in decreased expression of NPY mRNA | decreases expression | 18627777
|
D005947 |
Glucose |
Glucose results in decreased expression of NPY protein | decreases expression | 16210367
|
C514793 |
gp120 protein, Human immunodeficiency virus 1 |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of NPY mRNA | affects cotreatment|increases expression | 18606552
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of NPY mRNA | decreases expression | 16516965
|
D016627 |
Oxidopamine |
Oxidopamine results in increased expression of NPY mRNA | increases expression | 15303306
|
D007649 |
Ketamine |
NPY protein results in increased susceptibility to Ketamine | increases response to substance | 11454027
|
D008094 |
Lithium |
Lithium results in increased expression of NPY mRNA | increases expression | 17572454
|
D008094 |
Lithium |
Lithium results in increased expression of NPY protein | increases expression | 17572454
|
D008713 |
Methimazole |
Methimazole results in decreased expression of NPY mRNA | decreases expression | 17403546
|
D008713 |
Methimazole |
Methimazole results in increased expression of NPY mRNA | increases expression | 17403546
|
D018817 |
N-Methyl-3,4-methylenedioxyamphetamine |
N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NPY mRNA | decreases expression | 19285098
|
D009020 |
Morphine |
Morphine results in increased expression of NPY mRNA | increases expression | 20144693
|
C076029 |
olanzapine |
olanzapine results in decreased expression of NPY mRNA | decreases expression | 16516965
|
D010126 |
Ozone |
Ozone results in increased expression of NPY mRNA | increases expression | 16716893
|
C076213 |
PD 142893 |
PD 142893 inhibits the reaction [EDN1 protein results in decreased secretion of NPY protein] | decreases reaction|decreases secretion | 12234805
|
D010424 |
Pentobarbital |
NPY1R protein affects the reaction [NPY protein results in increased susceptibility to Pentobarbital] | affects reaction|increases response to substance | 11454027
|
D010424 |
Pentobarbital |
NPY protein results in increased susceptibility to Pentobarbital | increases response to substance | 11454027
|
C494474 |
perchlorate |
perchlorate results in decreased expression of NPY mRNA | decreases expression | 17403546
|
C494474 |
perchlorate |
perchlorate results in increased expression of NPY mRNA | increases expression | 17403546
|
D010615 |
Phenacetin |
Phenacetin results in increased expression of NPY mRNA | increases expression | 17082564
|
D010656 |
Phenylephrine |
NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]] | affects reaction|increases phosphorylation|increases reaction | 10660688
|
D010656 |
Phenylephrine |
NPY5R protein affects the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]] | affects reaction|increases phosphorylation|increases reaction | 10660688
|
D010656 |
Phenylephrine |
NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 10660688
|
D010656 |
Phenylephrine |
NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein] | increases phosphorylation|increases reaction | 10660688
|
D010656 |
Phenylephrine |
[Phenylephrine co-treated with ADRA1B protein] results in decreased expression of NPY protein | affects cotreatment|decreases expression | 11499749
|
D010656 |
Phenylephrine |
Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 10660688
|
D010656 |
Phenylephrine |
Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]] | decreases reaction|increases phosphorylation|increases reaction | 10660688
|
C030299 |
phenylhydrazine |
phenylhydrazine results in increased expression of NPY mRNA | increases expression | 17082564
|
D010665 |
Phenylpropanolamine |
Phenylpropanolamine results in decreased expression of NPY mRNA | decreases expression | 17684035
|
D010665 |
Phenylpropanolamine |
Phenylpropanolamine results in decreased expression of NPY protein | decreases expression | 17684035
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of NPY mRNA | decreases expression | 17426115
|
D011188 |
Potassium |
NPY protein inhibits the reaction [CALCA protein affects the susceptibility to Potassium] | affects response to substance|decreases reaction | 18055875
|
D011188 |
Potassium |
Capsaicin inhibits the reaction [NPY protein affects the susceptibility to Potassium] | affects response to substance|decreases reaction | 18055875
|
D011188 |
Potassium |
NPY protein inhibits the reaction [CALCA protein affects the susceptibility to Potassium] | affects response to substance|decreases reaction | 18055875
|
D011188 |
Potassium |
NPY protein results in increased susceptibility to Potassium | increases response to substance | 18055875
|
D011374 |
Progesterone |
Progesterone results in increased expression of NPY mRNA | increases expression | 18070364
|
D011441 |
Propylthiouracil |
Propylthiouracil results in decreased expression of NPY mRNA | decreases expression | 17403546
|
D011441 |
Propylthiouracil |
Propylthiouracil results in increased expression of NPY mRNA | increases expression | 17403546
|
D019257 |
Quinpirole |
NPY protein results in decreased susceptibility to [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole] | affects cotreatment|decreases response to substance | 12183048
|
C087120 |
RES 701-1 |
RES 701-1 inhibits the reaction [EDN1 protein results in decreased secretion of NPY protein] | decreases reaction|decreases secretion | 12234805
|
D013311 |
Streptozocin |
INS protein inhibits the reaction [Streptozocin results in increased expression of NPY mRNA] | decreases reaction|increases expression | 20219977
|
D013311 |
Streptozocin |
Streptozocin results in increased expression of NPY mRNA | increases expression | 20219977
|
D013549 |
Sweetening Agents |
Sweetening Agents results in decreased expression of NPY mRNA | decreases expression | 18627777
|
D013726 |
Terbutaline |
NPY protein inhibits the reaction [Terbutaline results in increased secretion of GCG protein] | decreases reaction|increases secretion | 3329090
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NPY mRNA | decreases expression | 19465110
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of NPY mRNA | affects expression | 15977195
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with LEP protein] affects the expression of NPY mRNA | affects cotreatment|affects expression | 15977195
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NPY mRNA | increases expression | 15093705
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 10660688
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate inhibits the reaction [NPY protein promotes the reaction [Phenylephrine results in increased phosphorylation of MAPK3 protein]] | decreases reaction|increases phosphorylation|increases reaction | 10660688
|
D015647 |
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
NPY protein results in decreased susceptibility to [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole] | affects cotreatment|decreases response to substance | 12183048
|
C052342 |
topiramate |
topiramate results in increased expression of NPY protein | increases expression | 17572454
|
C062527 |
tribromoethanol |
NPY protein results in increased susceptibility to tribromoethanol | increases response to substance | 11454027
|
C034028 |
vanadyl sulfate |
vanadyl sulfate results in increased expression of NPY mRNA | increases expression | 11294500
|
D020888 |
Vigabatrin |
Vigabatrin results in increased expression of NPY mRNA | increases expression | 16194568
|
D020888 |
Vigabatrin |
Vigabatrin results in increased expression of NPY protein | increases expression | 16194568
|
C022189 |
zonisamide |
zonisamide results in increased expression of NPY protein | increases expression | 16194568
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
16.16 | 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
16.16 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Terbutaline |
16.16 | 14610225 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
16.16 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.72 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.72 | 11192467 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
4.07 | 18460982 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.63 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.15 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.15 | 16835633 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.54 | 12649775 14617031 16160616 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.78 | 15451039 15451040 |
MESH:D000437 |
Alcoholism |
marker/mechanism |
|
| 17572454 |
MESH:D000437 |
Alcoholism |
|
topiramate |
4.62 | 19331489 18552399 17925516 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
4.31 | 17569567 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
4.22 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.22 | 15513908 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.53 | 16459022 18475255 15010207 16916582 |
MESH:D000686 |
Amyloidosis |
|
Terbutaline |
5.12 | 7986221 |
MESH:D000740 |
Anemia |
|
Phenacetin |
12.49 | 2444515 |
MESH:D000740 |
Anemia |
|
phenylhydrazine |
12.49 | 2444515 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
12.49 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Phenacetin |
9.48 | 17698508 17082564 1949026 |
MESH:D000743 |
Anemia, Hemolytic |
|
phenylhydrazine |
9.48 | 17084956 17082564 17698508 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Aspartame |
5.55 | 11372003 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.30 | 15513904 |
MESH:D000855 |
Anorexia |
marker/mechanism |
|
| 16084549 16101753 |
MESH:D000855 |
Anorexia |
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
25.76 | 12183048 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
25.76 | 12183048 16084549 16101753 12005258 |
MESH:D000855 |
Anorexia |
|
N-Methyl-3,4-methylenedioxyamphetamine |
25.76 | 15146954 |
MESH:D000855 |
Anorexia |
|
Phenylpropanolamine |
25.76 | 17684035 |
MESH:D000855 |
Anorexia |
|
Quinpirole |
25.76 | 12183048 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
8.01 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
8.01 | 18313124 11141031 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.66 | 17460149 |
MESH:D001169 |
Arthritis, Experimental |
|
bis(maltolato)oxovanadium(IV) |
4.97 | 17696279 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Aspartame |
4.80 | 10777254 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.80 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.46 | 17854713 16373670 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Oxidopamine |
4.29 | 14699433 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.55 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.55 | 17069543 18685284 |
MESH:D001321 |
Autistic Disorder |
|
Terbutaline |
2.55 | 17400887 16417856 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
7.26 | 17594078 19153942 20338123 20046352 |
MESH:D001714 |
Bipolar Disorder |
|
zonisamide |
7.26 | 15383137 16855456 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
12.62 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
12.62 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
12.62 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.25 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.41 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.39 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
14.87 | 18207255 |
MESH:D001919 |
Bradycardia |
|
Carbachol |
14.87 | 12411408 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
14.87 | 15306635 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.80 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.74 | 15665606 15845082 15380490 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
9.13 | 19211983 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
9.13 | 19211983 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.97 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Deoxyglucose |
1.97 | 18985042 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.97 | 16175315 17614352 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.26 | 18315731 16777450 15516495 19059883 18417511 14754758 17626835 |
MESH:D002056 |
Burns |
|
Ethanol |
4.14 | 16374292 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.21 | 16183385 |
MESH:D019559 |
Capillary Leak Syndrome |
|
Terbutaline |
5.32 | 11713377 9428835 |
MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
5.06 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.38 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
2.34 | 18788625 15763234 15289165 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.46 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
2.79 | 18922899 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
9.67 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
9.67 | 11754973 17287366 17124262 16170337 15728586 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
9.67 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.35 | 10591146 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.38 | 1977408 15215559 |
MESH:D002389 |
Catatonia |
|
olanzapine |
5.71 | 16772815 18071103 |
MESH:D002544 |
Cerebral Infarction |
marker/mechanism |
|
| 11821007 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
topiramate |
3.88 | 15650499 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.72 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.43 | 19176532 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.29 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.13 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.13 | 16354765 15340226 15668235 12621046 8697196 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.45 | 17123785 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.61 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
4.12 | 18504504 |
MESH:D003371 |
Cough |
|
Capsaicin |
9.87 | 10350223 |
MESH:D003371 |
Cough |
|
Terbutaline |
9.87 | 19679606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
2.43 | 15513904 11198716 15451039 11873399 15451040 19302082 10194807 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.43 | 15322242 10048152 20055451 |
MESH:D007644 |
Darier Disease |
|
Lithium |
5.38 | 20338123 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.36 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.11 | 11575062 |
MESH:D003731 |
Dental Caries |
|
Aspartame |
6.39 | 8955999 |
MESH:D003866 |
Depressive Disorder |
therapeutic |
|
| 17572454 |
MESH:D003866 |
Depressive Disorder |
|
zonisamide |
4.53 | 16855456 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Aspartame |
4.23 | 14996049 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.16 | 18249437 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.32 | 17069543 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.23 | 19244398 |
MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
4.28 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
bis(maltolato)oxovanadium(IV) |
16.49 | 12083368 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
16.49 | 18603373 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
16.49 | 8740154 19960420 12093613 7637645 17874149 15862027 19586609 19298542 15831366 15298345 18715473 12644472 11055810 12446591 12083368 17442507 1374869 16684804 16286809 2177838 19496084 6379147 18603373 11260395 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
16.49 | 16684804 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
3.45 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
11.97 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
11.97 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
11.97 | 19647726 19586609 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
11.97 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
topiramate |
11.97 | 16979414 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.20 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
4.23 | 19682444 19960420 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.98 | 17187935 |
MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
4.92 | 17662242 |
MESH:D003967 |
Diarrhea |
|
Morphine |
4.03 | 2540324 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.02 | 15331141 |
OMIM:607208 |
DRAVET SYNDROME |
|
zonisamide |
5.54 | 11748493 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
3.34 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.34 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.22 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
7.22 | 7515130 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
4.20 | 11535926 10671773 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.80 | 16402076 |
MESH:D004487 |
Edema |
|
pirinixic acid |
8.77 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.77 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
8.77 | 11698051 9599246 16716910 8113982 15177302 8273558 7812673 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.36 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.28 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.41 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.41 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
zonisamide |
5.31 | 3659116 3691417 |
MESH:D004828 |
Epilepsies, Partial |
|
zonisamide |
5.05 | 15140322 11558140 3691417 |
MESH:D004827 |
Epilepsy |
|
topiramate |
6.83 | 19148780 |
MESH:D004827 |
Epilepsy |
|
zonisamide |
6.83 | 20196486 |
MESH:D004833 |
Epilepsy, Temporal Lobe |
|
topiramate |
5.74 | 16499746 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
zonisamide |
5.21 | 3659116 3691417 |
MESH:D004893 |
Erythema Nodosum |
|
Aspartame |
6.39 | 9324739 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
5.18 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.61 | 16704527 |
MESH:D020329 |
Essential Tremor |
|
zonisamide |
5.66 | 17149715 18297619 |
MESH:D005076 |
Exanthema |
|
zonisamide |
5.55 | 15140322 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.61 | 11564622 |
MESH:D005141 |
Eyelid Diseases |
|
Aspartame |
5.84 | 14996049 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
11.02 | 19890266 |
MESH:D005221 |
Fatigue |
|
zonisamide |
11.02 | 17149715 |
MESH:D005234 |
Fatty Liver |
|
Dietary Sucrose |
19.76 | 17967931 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
19.76 | 16409862 19236843 18620774 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
19.76 | 18395287 18641190 19196556 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
19.76 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
19.76 | 18299183 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.13 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.77 | 10194807 15513904 16946407 15451040 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.94 | 11858732 |
MESH:D005334 |
Fever |
|
Aspartame |
4.87 | 9630831 |
MESH:D005355 |
Fibrosis |
|
Fructose |
12.16 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Terbutaline |
12.16 | 15467267 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.16 | 20067830 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.16 | 15046732 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
3.77 | 18405923 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
4.84 | 19165636 |
MESH:D006042 |
Goiter |
|
perchlorate |
4.82 | 18801409 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.05 | 10696789 |
MESH:D006261 |
Headache |
|
Ketamine |
10.10 | 11554966 |
MESH:D006261 |
Headache |
|
zonisamide |
10.10 | 17149715 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
5.18 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
6.02 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.02 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Streptozocin |
3.90 | 12093613 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.20 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.86 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.56 | 16221962 19772884 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.56 | 15340226 16120746 12621046 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.04 | 17457083 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.51 | 18606429 16354765 16959395 8697196 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
7.02 | 17434803 17043245 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
7.02 | 18783367 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.46 | 18360027 14757778 15752949 18563319 19008412 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
10.05 | 1977408 14960337 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
10.05 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
4.27 | 15752949 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
5.70 | 17933447 |
MESH:D006973 |
Hypertension |
|
Aspartame |
10.63 | 18708962 |
MESH:D006973 |
Hypertension |
|
Fructose |
10.63 | 14633139 19008412 16843071 14573337 14568997 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
10.63 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
10.63 | 18670907 18850075 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.11 | 14678291 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.62 | 19799862 19342510 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.08 | 12791704 18502941 |
MESH:D006985 |
Hyperventilation |
|
Terbutaline |
5.55 | 10895896 |
MESH:D007008 |
Hypokalemia |
|
Terbutaline |
5.56 | 17292646 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Potassium |
5.33 | 19822448 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
10.24 | 18031379 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
10.24 | 8137927 18031379 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.89 | 15869954 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
9.59 | 16956363 |
MESH:D007249 |
Inflammation |
|
Progesterone |
9.59 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.59 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
9.59 | 7562506 8273558 11698051 7812673 15177302 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
10.41 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
10.41 | 14573337 14757778 18981581 19342510 18563319 17133782 14633139 19008412 18057795 19799862 19586609 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
10.41 | 16306350 |
MESH:D002546 |
Ischemic Attack, Transient |
|
zonisamide |
6.36 | 9372210 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
8.54 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.54 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Aspartame |
6.12 | 11409539 |
MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
6.12 | 12093613 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.70 | 15451040 |
MESH:D053609 |
Lethargy |
|
Terbutaline |
5.78 | 10895896 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.43 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.58 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
3.07 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.57 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
3.03 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.03 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.03 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
3.12 | 16956363 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.14 | 17207112 17347304 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
3.51 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
3.51 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
1.78 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.32 | 20210726 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.01 | 19066396 8266340 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
zonisamide |
5.39 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.34 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.09 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.09 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.09 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
4.26 | 8764131 17941976 8840982 9205081 11980663 9488045 18798262 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
8.17 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
8.17 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
8.17 | 8985016 |
MESH:D008545 |
Melanoma |
|
Glucose |
2.99 | 14993021 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.69 | 15451040 18411066 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
10.42 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
10.42 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
10.42 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
4.92 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
8.60 | 19142101 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
8.60 | 16815490 17098227 19165636 18497449 17261469 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.57 | 10496685 |
MESH:D008708 |
Methemoglobinemia |
|
Phenacetin |
4.47 | 1949026 16296465 3537620 4834387 |
MESH:D008881 |
Migraine Disorders |
|
Aspartame |
7.39 | 18627677 10792367 |
MESH:D008881 |
Migraine Disorders |
|
topiramate |
7.39 | 18765137 18759728 18803445 16942474 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
4.98 | 1613127 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
7.01 | 17505005 |
MESH:D009101 |
Multiple Myeloma |
|
zonisamide |
7.01 | 11868602 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.99 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
5.25 | 16288908 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.25 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.60 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.54 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
zonisamide |
5.66 | 9477142 |
MESH:D009325 |
Nausea |
|
zonisamide |
5.47 | 16855456 |
MESH:D009369 |
Neoplasms |
|
Aspartame |
4.63 | 16507461 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.63 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
4.59 | 8764131 9488045 9205081 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
7.92 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
7.92 | 14600291 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
5.79 | 17292584 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
7.92 | 15183010 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Oxidopamine |
7.92 | 18514411 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
4.60 | 17961222 |
MESH:D009765 |
Obesity |
|
Capsaicin |
12.47 | 19056576 |
MESH:D009765 |
Obesity |
|
Clozapine |
12.47 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
Fructose |
12.47 | 18585860 17707055 |
MESH:D009765 |
Obesity |
|
olanzapine |
12.47 | 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
12.47 | 20558911 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Terbutaline |
5.57 | 14998686 |
MESH:D010003 |
Osteoarthritis |
|
Aspartame |
4.54 | 9630831 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.46 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.35 | 16525653 17393432 |
MESH:D010146 |
Pain |
|
Aspartame |
12.88 | 9630831 |
MESH:D010146 |
Pain |
|
Capsaicin |
12.88 | 17084039 19081190 18987195 16996476 17434803 17043245 |
MESH:D010146 |
Pain |
|
Morphine |
12.88 | 16273134 6776300 15275824 18699797 20225289 15215642 |
MESH:D010146 |
Pain |
|
zonisamide |
12.88 | 17666864 16217643 15140322 |
MESH:D010149 |
Pain, Postoperative |
|
Ketamine |
5.59 | 11554966 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
4.97 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
4.97 | 15976015 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
3.78 | 12065085 18922899 8330346 18404319 |
MESH:D010292 |
Paresthesia |
|
zonisamide |
6.36 | 17149715 |
MESH:D010300 |
Parkinson Disease |
|
zonisamide |
3.99 | 17200492 11755227 20196486 19594199 13677302 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Oxidopamine |
4.94 | 11771942 15893579 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.71 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
gp120 protein, Human immunodeficiency virus 1 |
9.27 | 18606552 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
9.27 | 18606552 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.62 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.87 | 18007984 18381685 18929643 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.06 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
7.76 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.76 | 11222880 11399792 11118676 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.73 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
4.27 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Deoxyglucose |
4.27 | 18985042 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
10.10 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
10.10 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
7.86 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
7.86 | 11575062 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.26 | 10548101 |
MESH:D011654 |
Pulmonary Edema |
|
Terbutaline |
4.98 | 10903255 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.49 | 10930210 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
9.54 | 18460982 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
9.54 | 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
9.54 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Terbutaline |
4.57 | 2878809 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.33 | 18990726 |
MESH:D012220 |
Rhinitis |
marker/mechanism |
|
| 12746121 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.65 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
7.22 | 17667964 20521326 18855531 11763009 18806925 17726453 20107430 19369910 20168265 11151749 16141801 20580759 20521320 17123785 20452607 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
7.22 | 19369910 20107430 18513383 1830565 |
MESH:D012559 |
Schizophrenia |
|
Ketamine |
7.22 | 20000043 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
7.22 | 20521326 20107430 17726453 |
MESH:D012640 |
Seizures |
marker/mechanism |
|
| 16194568 |
MESH:D012640 |
Seizures |
|
Deoxyglucose |
22.52 | 17978042 |
MESH:D012640 |
Seizures |
|
Ethanol |
22.52 | 9754883 |
MESH:D012640 |
Seizures |
|
Lithium |
22.52 | 19660546 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
22.52 | 10087439 9754883 |
MESH:D012640 |
Seizures |
|
topiramate |
22.52 | 16499746 |
MESH:D012640 |
Seizures |
|
Vigabatrin |
22.52 | 10454489 9844417 |
MESH:D012640 |
Seizures |
|
zonisamide |
22.52 | 16938433 11755227 16180713 11879338 9806000 9844417 11442880 11518630 15946322 11044598 10029267 9046859 18455367 12941455 16876388 |
MESH:D012772 |
Shock, Septic |
|
Terbutaline |
4.97 | 3431524 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.18 | 7327846 |
MESH:D012859 |
Sjogren's Syndrome |
|
Aspartame |
6.04 | 16800424 |
MESH:D012878 |
Skin Neoplasms |
|
Glucose |
8.07 | 14993021 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.07 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.07 | 18404319 8985016 8330346 11807781 12065085 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.75 | 16503802 15862959 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
11.49 | 19430551 19951488 19570321 |
MESH:D013226 |
Status Epilepticus |
|
zonisamide |
11.49 | 12833885 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
5.88 | 1977408 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
zonisamide |
5.31 | 12239465 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.30 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.08 | 17918041 16755016 17189318 9211565 9562338 11906479 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.46 | 16684133 16045194 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
8.73 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
8.73 | 11529278 9754883 |
MESH:D013436 |
Sulfhemoglobinemia |
|
Phenacetin |
6.02 | 978859 |
MESH:D013610 |
Tachycardia |
|
Terbutaline |
5.00 | 10895896 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
9.29 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
9.29 | 20210726 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
5.19 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
|
Aspartame |
5.02 | 17534100 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.36 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
3.28 | 15710170 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
zonisamide |
5.66 | 11814737 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Phenacetin |
3.60 | 11144890 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.47 | 14652134 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.05 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Dietary Sucrose |
5.39 | 18551017 |
MESH:D014839 |
Vomiting |
|
zonisamide |
5.39 | 17157078 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.71 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
8.86 | 20564506 17502770 16402076 20521320 16141801 20107430 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
8.86 | 19434072 17933447 20107430 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.55 | 17933447 |